Introduction
============

Recurrent spontaneous miscarriage (RSM), defined as three or more consecutive losses before 20 weeks of gestation with the same partner ([@b1-etm-0-0-3796]), comprise a multifactorial condition enhanced by a variety of genetic, endocrine, anatomic, immunological, infectious, environmental, thrombophilic and metabolic factors ([@b2-etm-0-0-3796]). Regardless of extensive research undertaken in this field, the underlying cause of the majority (≤50%) of RSM cases remains unknown and hence poses a clinical challenge ([@b3-etm-0-0-3796]).

Toll-like receptors (TLRs), a recently identified group of vertebrate receptors, serve a pivotal role in immune responses. There are 10 TLRs expressed in humans ([@b4-etm-0-0-3796]), and Toll-like receptor 4 (TLR4) is one of the most actively investigated TLRs. TLR4 serves an essential role in the activation and regulation of the innate and acquired immune responses through the recognition of specific molecular patterns of pathogens and endogenous peptides ([@b5-etm-0-0-3796]).

Single-nucleotide polymorphisms (SNPs) are present in a number of TLR genes and have been implicated in the loss of self-tolerance, which may lead to autoimmunity and chronic inflammation ([@b6-etm-0-0-3796]). A number of studies have suggested that *TLR4* polymorphisms are associated with the development of chronic inflammatory conditions ([@b7-etm-0-0-3796],[@b8-etm-0-0-3796]), chronic granulomatous conditions ([@b9-etm-0-0-3796]) and cardivascular diseases ([@b10-etm-0-0-3796]).

To the best of our knowledge, there have been no previous studies on the association between the human *TLR4* gene and RSM in Uygur women in Xinjiang. The aim of the present study was to investigate the association between the human *TLR4* gene and RSM using a haplotype-based case-control study that employed SNPs in conjunction with separate analyses that examined the data with regard to Uygur and Han women.

Materials and methods
=====================

### Subjects

Subjects diagnosed with RSM were recruited at the First Affiliated Hospital of Xinjiang Medical University in Urumqi, China, between 2012 and 2014. A total of 306 RSM patients were enrolled in the present study, with a Uygur/Han ratio of 1.01. RSM was diagnosed based on the following criteria: Patients who had experienced the spontaneous loss of three or more consecutive pregnancies prior to 20 weeks of gestation were included in the RSM group. Patients diagnosed with chromosomal abnormalities, uterine abnormalities, hereditary thrombophilia, endocrinologic disorders, immunologic factors and infections were excluded. A total of 306 age-matched healthy individuals (Uygur/Han ratio, 1.03) were enrolled as controls. There was no history of abortions or fertility treatments and no normal menstrual cycles for the controls. Informed consent was obtained from each of the subjects in accordance with the protocol approved by the Human Studies Committee of Xingjiang Medical University.

### Genotyping

The human *TLR4* gene is located on chromosome 9q33.1, spans \~17 kilobase pairs and contains four exons. There are 920 SNPs for the human *TLR4* gene listed in the National Center for Biotechnology Information SNP database Build 130 (<http://www.ncbi.nlm.nih.gov/SNP>). Data for tag SNPs was screened using the International HapMap Project (<http://www.hapmap.org/index.html.ja>) using a cutoff level of r^2^ ≥0.5. According to the above criteria, rs1927914 (SNP1), rs1927911 (SNP2), rs4986790 (SNP3) and rs4986791 (SNP4) were selected for the present study. The structure of the human *TLR4* gene is presented in [Fig. 1](#f1-etm-0-0-3796){ref-type="fig"}.

Blood samples were collected from each participant and genomic DNA was extracted from peripheral blood leukocytes by phenol and chloroform extraction. DNA sequencing using the Sanger dideoxy method was performed by Polymorphic DNA Technologies (Alameda, CA, USA). The four SNPs that were used for complete sequencing of the *TLR4* region included a portion of the upstream region, introns and exons, and these were analyzed in patients and controls from the cohort. Sequencing reactions were performed by O&E High-Tech Corporation in Beijing, China, and sequencing primers were designed using Primer Premier 5.0 software (Palo Alto, CA, USA).

### Genotyping of novel SNPs

The detailed of genotyping of novel SNP have been previously described ([@b11-etm-0-0-3796]). Briefly, DNA sequencing of the complete *TLR4* region was performed using a polymerase chain reaction direct sequencing method, which identified a heterozygous variant in subjects with RSM and controls. The sense primer for SNP1 was 5′TAGCATGAGAAATGAGGAAGTAAGGG3′ and the antisense primer was 5′GAGCTATGATGAGGATTGAAAATGTGG3′. The sense primer for SNP2 was 5′TAGCTGGCTTCTGCAAGGAAT3′ and the antisense primer was 5′GGAGACTGTCTGGCAGTCAAGATGT3′. The sense primer for SNP3 was 5′GTCCCTGAACCCTATGAACTTTATCC3′ and the antisense primer was 5′TCCCACCTTTGTTGGAAGTGAAAG3′. The sense primer for SNP4 was 5′CTGGTGAGTGTGACTATTGAAAGGG3′ and the antisense primer was 5′TTAGTACCTGAAGACTGGAGAGTGAG3′. Genotypes were determined automatically by the signal processing algorithms of Genotyping Console software 4.1 (Cleveland, OH, USA). To aid in the comparison of the results, each scoring method were saved in two separate output files.

### Biochemical analysis

Serum concentrations of cholesterol and glucose were measuring using the standard methods employed by the Clinical Laboratory Department of the First Affiliated Hospital of Xinjiang Medical University.

### Statistical analysis

All continuous variables were expressed as the mean ± standard deviation. The Mann-Whitney U test was used to compare differences in continuous variables between RSM patients and controls. The Fisher\'s exact test was used to calculate differences in categorical variables. The Hardy-Weinberg equilibrium was analyzed using χ^2^ analysis. The Fisher\'s exact test was used to calculate differences in the distribution of genotypes and alleles between the RSM patients and controls. According to the genotype data resulting from the genetic variations, linkage disequilibrium analysis and haplotype-based case-control analysis was performed using the expectation maximization algorithm and SNPAlyze version 3.2 (Dynacom Co., Ltd., Yokohama, Japan). The four SNPs were used to perform pair-wise linkage disequilibrium analysis. D \>0.5 was used to assign SNP locations to one haplotype block. SNPs with r^2^ \<0.5 were selected as tagged. A permutation test was used to calculate the frequency distribution of the haplotypes and P-values in the haplotype-based case-control analysis. The contribution of major risk factors was assessed using logistic regression analysis. P\<0.05 was considered to indicate a statistically significant difference. Statistical analyses were performed using SPSS software for Windows (version 12; SPSS Inc., Chicago, IL, USA).

Results
=======

### Clinical characteristics

[Table I](#tI-etm-0-0-3796){ref-type="table"} presents the clinical characteristics of the study participants. In Uygur women, the age of menarche, systolic blood pressure, diastolic blood pressure and spontaneous miscarriages were significantly higher in RSM patients compared with the controls (P\<0.05). In Han women, systolic blood pressure, number of pregnancies, spontaneous miscarriages and the frequency of drinking were significantly higher in RSM patients compared with the controls (P\<0.05). There were no significant differences noted between RSM patients and the controls with regards to age, body mass index, pulse rate, serum cholesterol, serum glucose and the frequency of smoking in Uygur and Han women.

### Distribution of genotypes

[Table II](#tII-etm-0-0-3796){ref-type="table"} presents the distribution of the genotypes and alleles of the four SNPs. For each SNP, the genotype distributions in the controls were not significantly different from the Hardy-Weinberg equilibrium values (data not shown). In Uygur women, there were significant differences between the distributions of the rs1927914, rs1927911 and rs4986790 SNPs between the RSM patients and the controls (P=0.001, P\<0.001 and P=0.015, respectively). In Han women, there were significant differences between the distributions of the rs1927914 and rs1927911 SNPs between the RSM patients and the controls (P\<0.001 and P\<0.001, respectively).

### Risk factors and SNPs

Parameters in [Table I](#tI-etm-0-0-3796){ref-type="table"} that exhibited significant differences between the RSM patients and the controls were used for the logistic regression analysis. In Uygur women, parameters used included SNPs (rs1927914, rs1927911 and rs4986790), the age of menarche, systolic blood pressure, diastolic blood pressure and spontaneous miscarriages. As shown in [Table III](#tIII-etm-0-0-3796){ref-type="table"}, results of the logistic regression analysis indicated that the distributions of rs1927914, rs1927911 and rs4986790 SNPs were significantly different in the RSM patients compared with the control individuals (P=0.012, P=0.024 and P=0.035, respectively). In addition, systolic blood pressure differed significantly between the RSM patients and the controls (P=0.011, P=0.021 and P=0.032, respectively) in Uygur women.

In Han women, parameters used included SNPs (rs1927914 and rs1927911), systolic blood pressure, number of pregnancies, spontaneous miscarriages and the frequency of drinking. As shown in [Table IV](#tIV-etm-0-0-3796){ref-type="table"}, results of the logistic regression analysis indicated that the distributions of rs1927914 and rs1927911 SNPs were significantly different in the RSM patients compared with the control individuals (P=0.021 and P=0.004, respectively) in Han women.

### Haplotypes

Since most of the D-values of linkage disequilibrium for the human *TLR4* gene in the controls were \>0.5 (data not shown), this indicated that the four SNPs were located in one haplotype block. Since all of the r^2^ values were \<0.5 (data not shown), this suggests that every SNP would be useful for the haplotype-based case-control study. Since rs4986791 (SNP4) has no allele distributions in RSM patients and the controls in this study, haplotypes were constructed using SNP1, SNP2 and SNP3. The distributions of the individual haplotypes for these combinations of the three SNPs were analyzed, and the results are presented in [Table V](#tV-etm-0-0-3796){ref-type="table"}. In Uygur women, significantly higher frequencies were noted for the A-G-G haplotype (SNP1-SNP2-SNP3; P=0.016) in RSM patients compared with the controls.

Discussion
==========

RSM is a reproductive problem, which affects 1--3% of couples trying to conceive ([@b12-etm-0-0-3796]). Epidemiological studies have suggested that RSM comprises a multifactorial condition enhanced by a variety of genetic and environmental factors ([@b13-etm-0-0-3796]). A number of studies have suggested that RSM is associated with genetic disorders that include skewed X chromosome inactivation ([@b14-etm-0-0-3796]), HLA-G ([@b15-etm-0-0-3796]), age-related aneuploidy ([@b16-etm-0-0-3796]), autoimmune disorders ([@b17-etm-0-0-3796]) and acquired or inherited thrombophilia ([@b18-etm-0-0-3796]). In addition, several studies have shown that nutritional and lifestyle factors, smoking, and diet ([@b19-etm-0-0-3796],[@b20-etm-0-0-3796]) contribute to RSM pathogenesis. For instance, obesity has a greater incidence in RSM patients compared with controls ([@b21-etm-0-0-3796]). Furthermore, a woman\'s medical history ([@b3-etm-0-0-3796]) is important since the risk of RSM is increased by previous miscarriages (20% after one miscarriage, 28% after two miscarriages) and age (40% risk for 40 year-old women, and 80% for women 45 and older). Considering all these risk factors, the related data (including age, body mass index, number of pregnancies and number of spontaneous miscarriages) has been collected and presented in [Table I](#tI-etm-0-0-3796){ref-type="table"}. Then, the relationship between these risk factors and RSM is analyzed using logistic regression and presented in [Tables III](#tIII-etm-0-0-3796){ref-type="table"} and [IV](#tIV-etm-0-0-3796){ref-type="table"}.

TLR4 is present in numerous cell types and signals the innate immune response. TLR4 expression has been investigated in tumor cells or cell lines, including extranodal marginal zone B-cell lymphomas, gastric carcinoma, hepatocellular carcinoma cells, pituitary epithelial tumor cell lines, colon cancer cells and human prostate epithelial PC3 cells ([@b22-etm-0-0-3796]). The innate immune system is the first line of defense against microbial infection and TLR4 serves as the first point of defense in the innate immune system. TLR4 is one of the most extensively investigated TLRs and recognizes endotoxic lipopoly saccharide (LPS) in the outer membrane of Gram-negative bacteria with its co-receptor MD-2 ([@b23-etm-0-0-3796]). TLR4 is critical in the recognition of viruses and bacteria, serving as a key immune system effector. Excessive signaling in response to LPS frequently results in uncontrolled amplification of inflammatory responses, leading to fatal septic shock ([@b24-etm-0-0-3796],[@b25-etm-0-0-3796]).

Dysregulation of TLR4 signalling owing to SNPs may alter the ligand binding and balance between pro- and anti-inflammatory cytokines, thereby modulating the risk of chronic inflammatory and immune disorders. Consequently, several studies have shown that common SNPs of a series of low penetrance alleles of TLR4, modified during the above mentioned processes, are likely to serve an important role in cancer susceptibility ([@b26-etm-0-0-3796],[@b27-etm-0-0-3796]). Two SNPs of the human TLR4, A299G (ref SNP ID: rs4986790, SNP3) and T399I (ref SNP ID: rs4986791, SNP4), have been identified and suggested to be associated with LPS hyporesponsiveness ([@b28-etm-0-0-3796],[@b29-etm-0-0-3796]). Furthermore, two non-synonymous polymorphisms of TLR4 (Asp299Gly and Thr399Ile) have been suggested to alter the function of the receptor ([@b30-etm-0-0-3796],[@b31-etm-0-0-3796]) and have been related to the development of chronic inflammatory conditions ([@b32-etm-0-0-3796]). In addition, Hirschfeld *et al* ([@b33-etm-0-0-3796]) reported that there was no association between fetal TLR4 polymorphisms, Asp299Gly and Thr399Ile, known to blunt LPS responsiveness, and the risk of idiopathic, chromosomally normal miscarriage. However, how the SNPs affect the function of TLR4 remains largely unknown.

The aim of the present study was to assess the association between the human *TLR4* gene and RSM in Uygur and Han women in Xinjiang by using a haplotype-based case-control study. The results of the genotype distributions and logistic regression analysis indicated that rs1927914, rs1927911 and rs4986790 are most likely associated with RSM in Uygur women, while rs1927914 and rs1927911 are most likely associated with RSM in Han women. Additionally, logistic regression analysis indicated that systolic blood pressure is one of the risk factors for RSM patients, which is consistent with results of a previous study ([@b34-etm-0-0-3796]).

It has been demonstrated that haplotypes can provide valuable information that can be used for predicting the severity and prognosis of certain genetic disorders ([@b35-etm-0-0-3796]). With the dramatic increase in the number of available SNP markers, haplotyping based on genotype data has become an important component of genetic studies in general and has shown that these types of studies have a number of advantages over analyses that are just based on individual SNPs ([@b36-etm-0-0-3796]). In the present study, haplotypes for the human *TLR4* gene were successfully established that were created from the combinations of the three SNPs. In the present haplotype analysis, there was a significantly higher frequency of the A-G-G haplotype (SNP1-SNP2-SNP3) in RSM patients compared with the controls in Uygur women. Therefore, it can be suggested that the result indicates that the A-G-G haplotype (SNP1-SNP2-SNP3) is the susceptibility haplotype for RSM in Uygur women, and it can be proposed that the A-G-G haplotype (SNP1-SNP2-SNP3) should be regarded as the genetic marker for RSM in Uygur women in Xinjiang. In addition, for SNP3, the G allele is the risk allele while the A allele is the safe allele for RSM in Uygur women.

To date, to the best of our knowledge, there have been no previous studies that have reported data on the association between TLR4 and RSM in Uygur women. Therefore, the current results provide novel data on the possibility that the *TLR4* gene is most likely associated with RSM, and rs4986790 may be the nationality-specific genetic marker for RSM for Uygur women.

In conclusion, the present study examined the association between the human *TLR4* gene and RSM. The present results indicate that rs1927914, rs1927911, rs4986790 and the A-G-G haplotype of the human *TLR4* gene may be genetic markers for RSM in Uygur women in Xinjiang. In addition, the results suggest that rs1927914 and rs1927911 of the human *TLR4* gene are most likely associated with RSM in Han women. Further studies are required to elucidate the functional association of TLR4 with RSM progression.

![Structure of the human *TLR4* gene. The gene consists of four exons (boxes) separated by three introns. Lines connecting the boxes indicate introns and intergenic regions. The filled boxes show the coding region. Arrows indicate the locations of single-nucleotide polymorphisms. Kbp, kilobase pairs.](etm-12-05-3268-g00){#f1-etm-0-0-3796}

###### 

Characteristics of study participants.

                                    Uygur        Han                                                                                            
  --------------------------------- ------------ ------------ ------------------------------------------------------- ------------ ------------ -------------------------------------------------------
  Number of subjects                154          155          --                                                      152          151          --
  Age (years)                       35.2±3.7     35.1±4.5     0.859                                                   35.6±4.1     35.7±3.8     0.643
  Body mass index (kg/m^2^)         23.2±2.9     22.8±2.7     0.261                                                   22.5±4.4     21.6±3.0     0.066
  Menarche (years)                  11.8±2.6     12.4±3.9     0.002^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^     12.3±3.9     12.5±4.2     0.127
  Systolic blood pressure (mmHg)    110.8±15.2   119.3±14.3   \<0.001^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^   113.1±14.7   120.8±13.6   \<0.001^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^
  Diastolic blood pressure (mmHg)   71.8±12.5    75.2±13.9    \<0.001^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^   75.5±9.7     76.6±11.4    0.232
  Pulse rate (beats/min)            75.8±8.1     75.1±7.2     0.356                                                   75.1±6.3     74.6±5.8     0.438
  Cholesterol (mmol/l)              5.3±1.1      4.7±0.9      0.061                                                   5.2±1.0      4.8±1.1      0.132
  Glucose (mmol/l)                  5.2±0.6      5.1±0.7      0.677                                                   5.4±0.3      5.3±0.8      0.547
  Number of pregnancies             4.5±0.7      4.1±0.5      0.125                                                   4.2±0.8      1.8±0.9      \<0.001^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^
  Spontaneous miscarriages          4.1±0.9      0±0.0        \<0.001^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^   3.8±0.7      0±0.0        \<0.001^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^
  Smoking (%)                       1.9          2.6          0.500                                                   3.3          3.3          0.621
  Drinking (%)                      12.3         13.5         0.321                                                   21.1         14.6         0.046^[a](#tfn1-etm-0-0-3796){ref-type="table-fn"}^

P\<0.05. Continuous variables are expressed as the mean ± standard deviation. P-values of continuous variables were calculated by Mann-Whitney U test. P-values of categorical variables were calculated by Fisher\'s exact test. RSM, recurrent spontaneous miscarriage.

###### 

Genotype and allele distributions in RSM patients and controls.

                     Uygur         Han                                                                                               
  ------------------ ------------- ------------- ------------------------------------------------------- ------------- ------------- -------------------------------------------------------
  rs1927914 (SNP1)                                                                                                                   
    Genotype                                                                                                                         
      A/A            88 (57.1%)    56 (36.1%)    0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^     90 (59.2%)    54 (35.8%)    \<0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^
      A/G            49 (31.8%)    65 (41.9%)                                                            48 (31.6%)    64 (42.4%)    
      G/G            17 (11.1%)    34 (22.0%)                                                            14 (9.2%)     33 (21.8%)    
    Allele                                                                                                                           
      A              225 (73.1%)   177 (57.1%)   \<0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^   228 (75.0%)   172 (57.0%)   \<0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^
      G              83 (26.9%)    133 (42.9%)                                                           76 (25.0%)    130 (43.0%)   
  rs1927911 (SNP2)                                                                                                                   
    Genotype                                                                                                                         
      G/G            90 (58.4%)    55 (35.5%)    \<0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^   91 (59.9%)    55 (36.4%)    \<0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^
      G/A            47 (30.5%)    73 (47.1%)                                                            45 (29.6%)    70 (46.4%)    
      A/A            17 (11.1%)    27 (17.4%)                                                            16 (10.5%)    26 (17.2%)    
    Allele                                                                                                                           
      G              227 (73.7%)   183 (59.0%)   \<0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^   227 (73.7%)   180 (59.6%)   \<0.001^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^
      A              81 (26.3%)    127 (41.0%)                                                           81 (26.3%)    122 (40.4%)   
  rs4986790 (SNP3)                                                                                                                   
    Genotype                                                                                                                         
      A/A            142 (92.3%)   152 (98.1%)   0.015^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^     148 (97.4%)   149 (98.7%)   0.345
      A/G            12 (7.7%)     3 (1.9%)                                                              4 (2.6%)      2 (1.3%)      
      G/G            0 (0.0%)      0 (0.0%)                                                              0 (0.0%)      0 (0.0%)      
    Allele                                                                                                                           
      A              296 (96.1%)   307 (99.0%)   0.016^[a](#tfn2-etm-0-0-3796){ref-type="table-fn"}^     296 (98.7%)   300 (99.3%)   0.340
      G              12 (3.9%)     3 (1.0%)                                                              4 (1.3%)      2 (0.7%)      
  rs4986791 (SNP4)                                                                                                                   
    Genotype                                                                                                                         
      C/C            154 (100%)    155 (100%)    --                                                      152 (100%)    151 (100%)    --
      C/T            0 (0%)        0 (0%)                                                                0 (0%)        0 (0%)        
      T/T            0 (0%)        0 (0%)                                                                0 (0%)        0 (0%)        
    Allele                                                                                                                           
      C              308 (100%)    310 (100%)    --                                                      304 (100%)    302 (100%)    --
      T              0 (0%)        0 (0%)                                                                0 (0%)        0 (0%)        

P\<0.05. P-values for genotype were calculated by Fisher\'s exact test. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.

###### 

Odds ratios and 95% confidence intervals for each risk factor and SNP associated with RSM in Uygur women.

                                      Uygur                   
  ----------------------------------- ------- --------------- -----------------------------------------------------
  rs1927914 (SNP1)                    6.86    1.934--46.950   0.012^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Menarche (years)                  0.731   0.343--1.524    0.419
    Systolic blood pressure (mmHg)    1.135   1.029--1.249    0.011^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Diastolic blood pressure (mmHg)   1.046   1.017--1.065    0.003^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Spontaneous miscarriages          0.672   0.413--1.089    0.121
  rs1927911 (SNP2)                    4.824   1.203--19.672   0.024^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Menarche (years)                  1.771   1.070--2.931    0.026^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Systolic blood pressure (mmHg)    2.421   1.091--5.297    0.021^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Diastolic blood pressure (mmHg)   0.673   0.383--1.182    0.172
    Spontaneous miscarriages          0.616   0.225--1.683    0.345
  rs4986790 (SNP3)                    8.272   1.168--40.358   0.035^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Menarche (years)                  1.121   0.351--3.562    0.852
    Systolic blood pressure (mmHg)    2.487   1.089--5.745    0.032^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^
    Diastolic blood pressure (mmHg)   1.405   0.648--3.031    0.386
    Spontaneous miscarriages          2.619   1.006--6.811    0.047^[a](#tfn3-etm-0-0-3796){ref-type="table-fn"}^

P\<0.05. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.

###### 

Odds ratios and 95% confidence intervals for each risk factor and SNP associated with RSM in Han women.

                                     Han                     
  ---------------------------------- ------- --------------- -----------------------------------------------------
  rs1927914 (SNP1)                   6.431   1.321--31.347   0.021^[a](#tfn4-etm-0-0-3796){ref-type="table-fn"}^
    Systolic blood pressure (mmHg)   1.967   1.071--3.589    0.037^[a](#tfn4-etm-0-0-3796){ref-type="table-fn"}^
    Number of pregnancies            1.185   0.597--2.358    0.634
    Spontaneous miscarriages         0.412   0.113--1.514    0.186
    Drinking (%)                     1.579   0.807--3.076    0.183
  rs1927911 (SNP2)                   2.234   1.271--3.917    0.004^[a](#tfn4-etm-0-0-3796){ref-type="table-fn"}^
    Systolic blood pressure (mmHg)   1.127   1.029--1.235    0.008^[a](#tfn4-etm-0-0-3796){ref-type="table-fn"}^
    Number of pregnancies            1.156   0.933--1.435    0.187
    Spontaneous miscarriages         1.046   1.022--1.074    0.001^[a](#tfn4-etm-0-0-3796){ref-type="table-fn"}^
    Drinking (%)                     1.970   0.632--6.145    0.249

P\<0.05. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.

###### 

Haplotype analysis in RSM patients and controls.

       Haplotype   Frequency in Uygur       Frequency in Han                                                                                 
  ---- ----------- -------------------- --- ------------------ ------- ----------------------------------------------------- ------- ------- -------
  H1   G           A                    A   0.164              0.236   0.756                                                 0.177   0.282   0.412
  H2   G           G                    A   0.086              0.187   0.298                                                 0.067   0.145   0.398
  H3   G           G                    G   0.019              0.006   0.540                                                 0.006   0.003   0.158
  H4   A           A                    A   0.099              0.174   0.389                                                 0.086   0.122   0.415
  H5   A           G                    A   0.632              0.393   0.633                                                 0.658   0.445   0.406
  H6   A           G                    G   0.020              0.004   0.016^[a](#tfn5-etm-0-0-3796){ref-type="table-fn"}^   0.006   0.003   0.137

P\<0.05. Haplotypes were estimated using SNPAlyze software. P-values were calculated by the permutation test. RSM, recurrent spontaneous miscarriage; SNP, single nucleotide polymorphism.
